Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement
Recruiting · NCT07184814 · Observational (researchers observe without assigning treatment) · Lead sponsor: China-Japan Friendship Hospital
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Hospitalized between Jan 1, 2016 and Dec 31, 2026
- Diagnosed with TAK according to the modified Ishikawa criteria and/or 1990 American College of Rheumatology criteria and/or 2022 ACR/EULAR criteria
- Diagnosed with pulmonary artery involvement using computed tomography pulmonary angiography or transcatheter pulmonary angiography
- Patients without aortic or primary branch involvement who nonetheless exhibited both clinical features and computed tomography-confirmed evidence of pulmonary artery involvement (PAI), after exclusion of other diseases causing pulmonary artery stenosis or occlusion
Exclusion criteria
- Patients with PAI caused by non-TAK diseases such as other types of vasculitis, fibrosing mediastinitis, pulmonary artery sarcoma, pulmonary sarcoidosis or chronic thromboembolic pulmonary hypertension
Where it is running
1 location listed.
- China-Japan Friendship hospital - Beijing, Beijing Municipality, China